Literature DB >> 31927649

Locally Advanced Rectal Cancer: Treatment Approach in Elderly Patients.

Francesca De Felice1, Daniele Crocetti2, Veronica Maiuri3, Martina Parisi3, Francesco Marampon3, Luciano Izzo2, Giorgio De Toma2, Daniela Musio3, Vincenzo Tombolini3.   

Abstract

Independently of age, evidence-based guidelines recommend a multidisciplinary treatment approach in patients with locally advanced rectal cancer (LARC). But actually, elderly patients are grossly underrepresented in clinical trials, accounting < 10% of enrolled cases. Therefore, LARC management in elderly patients remains a crucial issue in daily practice, especially due to their frailty. Multiple clinical factors, including general health status, cognitive status, co-morbidity, disability, and life expectancy should be considered to understand the complexities of geriatric assessment and then define therapy. We use a patient-centered approach in order to tailor the optimal treatment strategy. We treat fit elderly patients as younger patients, including neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy. Whereas, in vulnerable and frail patients, we propose standard CRT (vulnerable patients) or radiotherapy alone (frail patients).

Entities:  

Keywords:  Chemotherapy; Elderly; Multidisciplinary; Quality of life; Radiotherapy; Rectal cancer; Surgery; Survival; Treatment

Mesh:

Year:  2020        PMID: 31927649     DOI: 10.1007/s11864-019-0692-8

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  36 in total

1.  The Mini-Cog as a screen for dementia: validation in a population-based sample.

Authors:  Soo Borson; James M Scanlan; Peijun Chen; Mary Ganguli
Journal:  J Am Geriatr Soc       Date:  2003-10       Impact factor: 5.562

2.  Controversies of total mesorectal excision for rectal cancer in elderly patients.

Authors:  Harm J T Rutten; Marcel den Dulk; Valery E P P Lemmens; Cornelis J H van de Velde; Corrie A M Marijnen
Journal:  Lancet Oncol       Date:  2008-05       Impact factor: 41.316

Review 3.  Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment.

Authors:  Yves Guigoz; Sylvie Lauque; Bruno J Vellas
Journal:  Clin Geriatr Med       Date:  2002-11       Impact factor: 3.076

4.  Disease Control, Survival, and Toxicity Outcome After Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Single-Institution Experience.

Authors:  Francesca De Felice; Daniela Musio; Anna Lisa Magnante; Nadia Bulzonetti; Ilaria Benevento; Rossella Caiazzo; Vincenzo Tombolini
Journal:  Clin Colorectal Cancer       Date:  2016-02-13       Impact factor: 4.481

5.  Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.

Authors:  Xin An; Xi Lin; Feng-Hua Wang; Karyn Goodman; Pei-Qiang Cai; Ling-Heng Kong; Yu-Jing Fang; Yuan-Hong Gao; Jun-Zhong Lin; De-Sen Wan; Zhi-Zhong Pan; Pei-Rong Ding
Journal:  Eur J Cancer       Date:  2012-10-11       Impact factor: 9.162

6.  Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.

Authors:  Angelita Habr-Gama; Joaquim Gama-Rodrigues; Guilherme P São Julião; Igor Proscurshim; Charles Sabbagh; Patricio B Lynn; Rodrigo O Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

7.  Prognostic importance of comorbidity in a hospital-based cancer registry.

Authors:  Jay F Piccirillo; Ryan M Tierney; Irene Costas; Lori Grove; Edward L Spitznagel
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

8.  Preoperative chemoradiotherapy in elderly patients with locally advanced rectal cancer.

Authors:  Francesca De Felice; Daniela Musio; Luciano Izzo; Federico Pugliese; Paolo Izzo; Antonio Bolognese; Vincenzo Tombolini
Journal:  Biomed Res Int       Date:  2013-12-12       Impact factor: 3.411

9.  Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.

Authors:  Francesca De Felice; Ilaria Benevento; Anna Lisa Magnante; Daniela Musio; Nadia Bulzonetti; Rossella Caiazzo; Vincenzo Tombolini
Journal:  BMC Cancer       Date:  2017-05-12       Impact factor: 4.430

10.  Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older.

Authors:  Xin Cai; Hongbin Wu; Junjie Peng; Ji Zhu; Sanjun Cai; Gang Cai; Zhen Zhang
Journal:  Radiat Oncol       Date:  2013-04-10       Impact factor: 3.481

View more
  4 in total

1.  Impact of Age on Multimodality Treatment and Survival in Locally Advanced Rectal Cancer Patients.

Authors:  Lindsey C F De Nes; Thea C Heil; Rob H A Verhoeven; Valery E P P Lemmens; Harm J Rutten; Johannes H W De Wilt; Pauline A J Vissers
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

2.  MRI response rate after short-course radiotherapy on rectal cancer in the elderly comorbid patient: results from a retrospective cohort study.

Authors:  T Koëter; S G C van Elderen; G F A J B van Tilborg; J H W de Wilt; D K Wasowicz; T Rozema; D D E Zimmerman
Journal:  Radiat Oncol       Date:  2020-03-02       Impact factor: 3.481

3.  Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.

Authors:  Lina Wen; Zongqiang Han; Yanlin Du
Journal:  J Gastrointest Oncol       Date:  2021-06

Review 4.  Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?

Authors:  Clemens Seidel; Christine Viehweger; Rolf-Dieter Kortmann
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.